ArticleDrug safety2012
Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study.
Marjolein J C Willemen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it